#Japan #Kyoto #Omron Healthcare #AFib Detection #blood pressure monitor

OMRON Healthcare's Remarkable Achievement

In September 2025, OMRON HEALTHCARE Co., Ltd. declared a historic milestone: cumulative global sales of blood pressure monitors (BPMs) have crossed the 400 million mark. This significant achievement reflects a robust commitment to improving preventive healthcare and promoting cardiovascular awareness worldwide.

A Legacy of Innovation

The journey to this monumental figure began over fifty years ago when OMRON introduced its first-branded BPM in 1973, a time when blood pressure measurements were primarily conducted at hospitals and clinics. Today's landscape is vastly different; through technological advancements, individuals can now perform their blood pressure monitoring at home with ease and precision. As a leader in this sector, OMRON has continuously pushed the boundaries to enhance blood pressure management, focusing on early detection of potentially serious health conditions like atrial fibrillation (AFib).

Empowering Health Monitoring at Home

As healthcare evolves, OMRON remains at the forefront with solutions that enable effective home monitoring. Thanks to Bluetooth-enabled devices that sync with the OMRON connect app, users can easily visualize trends, share results with family, and keep their healthcare providers informed. The incorporation of AI technology, particularly the FDA-approved Intellisense AFib detection, exemplifies OMRON’s commitment to utilizing cutting-edge tools to facilitate timely health insights

The Complete monitor by OMRON not only tracks blood pressure but also provides ECG readings, allowing seamless communication and data sharing with healthcare professionals directly through the OMRON connect app.

Global Distribution and Impact

OMRON HealthCare’s products are now accessible in over 130 countries, and with this vast distribution network, the company is committed to ensuring that accurate, cost-effective blood pressure monitors reach emerging markets where preventive healthcare resources are scarce. The mission emphasizes reducing health disparities by enabling early intervention in communities that are most vulnerable.

“Selling over 400 million units signifies more than just a numeric achievement; it embodies the trust that countless individuals place in OMRON Healthcare to enable their pursuit of longer, healthier lives,” stated Ayumu Okada, President and CEO of OMRON HEALTHCARE Co., Ltd. “The quality and reliability of our blood pressure monitors are acknowledged globally among healthcare professionals. Our vision, 'Going for ZERO,' drives us to eradicate cerebro-cardiovascular incidents worldwide by creating technologies that seamlessly link daily life with healthcare, empowering individuals everywhere to engage in preventive actions.”

Innovative Future Ahead

As OMRON Healthcare steps into this new chapter, the company's advancements illustrate their focus on preventive care. Over the years, they have developed a series of cutting-edge technology innovations that enhance traditional BPMs into crucial preventive instruments. This includes remote monitoring initiatives fostered through partnerships with emerging healthcare companies such as Luscii, which expands their digital health business.

Conclusion

In conclusion, OMRON's achievement of exceeding 400 million blood pressure monitors not only marks a significant milestone in the company’s history but also serves as an important indicator of the growing awareness and importance of preventive cardiovascular care. With ongoing innovations and a strong commitment to global health, OMRON Healthcare continues to set the standard for the future of personal health management.